surpass 4 tirzepatide SURPASS-4 trial: slows rate of eGFR decline and reduces UACR in T2DM patients Lilly's tirzepatide achieves all primary
Pay in 4 interest-free payments of $6.03 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13




























